June 2017

Features

Pipeline for Neovascular AMD Runs Full

An update on small-molecule anti-VEGF agents, anti-angiopoietin-2 antibodies, topical drops and port delivery.

Evolving Role of Steroids in RVO and DME

A deep dive into what clinical trials report on the efficacy of corticosteroids for retinal disorders.

Treatments for Noninfectious Uveitis: Old Dogs and New Tricks

Acthar gel re-emerges, suprachoroidal triamcinolone acetonide emerges.

A Long-Term Game Plan for Noninfectious Uveitis

Treatment requires patience and a nuanced approach

Cataract Surgery Update for Retina Surgeons

Departments

Clinical Trial Closeup

FA Insert Delivers At 12 Months

Top-line results through 12 months show sustained effect of three-year insert for noninfectious posterior uveitis.

Coding Commentary

Reporting Self-Identified Overpayments

What the 60-day rule for Medicare overpayments really means.

Editor's Page

Summer Reading

Innovation Insight

Can Sirolimus Solve the Taper Puzzle?

SAKURA results point the way to successful tapering of steroids in noninfectious posterior uveitis.

Letters To Editor

Pharmacogenetics and AMD: Is AREDS Helpful? An Industry CEO Weighs In

Medical Retina Fellows Forum

Double-Layer Sign and Type 1 CNV

How OCT can be a powerful tool for detecting choroidal neovascularization in a variety of retinal diseases.

News

Study Evaluates Risks For Steroid-Induced IOP Rise in Uveitis

Retina CEO

Making the Case for SOPs

Standard operating procedures can save time and effort for practices participating in clinical trials.

Retina Rounds

Why Lesions and After-Image?

Concern for retinal tears in the fellow eye leads to a workup that goes in a different direction.

Surgical Pearl Video

Air and Oil: Friend and Foe

Pearls for using or removing an air bubble to ensure a perfect silicone oil fill.